Cwm LLC Purchases 447 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Cwm LLC lifted its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 341.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 578 shares of the medical instruments supplier’s stock after buying an additional 447 shares during the period. Cwm LLC’s holdings in ICU Medical were worth $58,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. SG Americas Securities LLC purchased a new position in ICU Medical in the fourth quarter worth $106,000. Private Trust Co. NA boosted its holdings in shares of ICU Medical by 273.8% in the 4th quarter. Private Trust Co. NA now owns 1,200 shares of the medical instruments supplier’s stock worth $120,000 after buying an additional 879 shares during the last quarter. Knights of Columbus Asset Advisors LLC grew its position in ICU Medical by 16.7% during the third quarter. Knights of Columbus Asset Advisors LLC now owns 1,848 shares of the medical instruments supplier’s stock valued at $220,000 after buying an additional 264 shares during the period. Xponance Inc. grew its position in ICU Medical by 17.8% during the third quarter. Xponance Inc. now owns 2,902 shares of the medical instruments supplier’s stock valued at $345,000 after buying an additional 439 shares during the period. Finally, Dark Forest Capital Management LP purchased a new stake in ICU Medical during the third quarter worth about $383,000. 96.10% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, KeyCorp increased their target price on shares of ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research report on Wednesday, February 28th. One investment analyst has rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $123.00.

ICU Medical Trading Down 1.1 %

Shares of ICUI opened at $100.60 on Thursday. ICU Medical, Inc. has a fifty-two week low of $78.28 and a fifty-two week high of $212.43. The business has a 50-day moving average of $100.55 and a 200 day moving average of $97.11. The firm has a market cap of $2.45 billion, a P/E ratio of -81.79 and a beta of 0.72. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.06 and a current ratio of 2.53.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.39. The firm had revenue of $587.86 million during the quarter, compared to the consensus estimate of $564.77 million. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. As a group, research analysts forecast that ICU Medical, Inc. will post 3.53 EPS for the current year.

Insiders Place Their Bets

In other news, VP Daniel Woolson sold 791 shares of ICU Medical stock in a transaction on Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares in the company, valued at $1,373,814.60. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other ICU Medical news, VP Daniel Woolson sold 791 shares of ICU Medical stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the transaction, the vice president now owns 13,980 shares of the company’s stock, valued at approximately $1,373,814.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Christian B. Voigtlander sold 13,603 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $107.19, for a total transaction of $1,458,105.57. The disclosure for this sale can be found here. Insiders have sold a total of 24,262 shares of company stock worth $2,545,532 over the last 90 days. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.